What is peptide therapy? What the term covers, and how much evidence sits behind each peptide

“Peptide therapy” sounds like one treatment. It is not. Your endocrinologist uses the phrase for insulin and GLP-1 medicines that went through years of trials. A wellness clinic uses it for a menu of injections promising recovery, fat loss and anti-aging. An influencer uses it for whatever is in this month’s stack. Same two words, very different evidence. This page explains what the term means in each setting, which substances it usually covers, and how much research sits behind each one, with every claim linked to its source. It is educational only, not medical advice.

What is peptide therapy?

Peptide therapy is treatment with peptides, which are short chains of amino acids, the same building blocks that make up proteins. A 2022 review in Signal Transduction and Targeted Therapy describes therapeutic peptides as a class of drugs usually weighing 500 to 5,000 daltons, and counts more than 80 peptide drugs approved worldwide counting from insulin in 1921, which it calls the first therapeutic peptide (Wang et al., 2022). So in the strict medical sense, peptide therapy is old, established pharmacology.

The phrase as people search for it today means something narrower and newer. As Anthony Tam, MD, a family and sports medicine physician at Henry Ford Health, put it to the American Medical Association in April 2026: “We’re now seeing a wave of other peptide injections that are being marketed by wellness centers and social media influencers,” many of which have not been thoroughly tested or reviewed by the FDA. For a primer on what peptides are in the first place, see what are peptides.

What does “peptide therapy” mean at a clinic, a telehealth app, or from an influencer?

It depends on who is saying it, and the gap between the meanings is the most useful thing to understand about the term.

• A doctor’s office or hospital. Usually an approved peptide drug for a diagnosed condition: insulin for diabetes, or a GLP-1 medicine such as semaglutide (Wegovy) or tirzepatide (Zepbound) for diabetes or obesity. Dr. Tam notes that for GLP-1 medicines doctors have well-established guidelines for who is a good candidate.
• A wellness clinic or anti-aging practice. Usually a “protocol” of peptides aimed at recovery, body composition, sleep, skin or longevity: BPC-157, TB-500, CJC-1295 with ipamorelin, GHK-Cu, epitalon and similar. Most are not FDA-approved drugs. When a pharmacy compounds them, the FDA says plainly that compounded drugs are not FDA-approved, which means it does not check their safety, effectiveness or quality before they are sold.
• A telehealth app. The same menu delivered online: an intake form, sometimes labs, a video or async visit, and a compounded product shipped from a pharmacy. Our sister site explains how online prescribing of peptides works.
• An influencer or podcast. Often the broadest meaning of all, covering clinic protocols, “research use only” vials bought online, and personal stacks. Dr. Tam told the AMA the users range from high school and college students in the online “looksmaxxing” community to weekend warriors and middle-aged people looking for an extra edge.

The practical takeaway: when someone says “peptide therapy,” ask which peptide. That one question tells you whether you are talking about a drug with phase 3 trials or a compound tested mostly in rats.

Which substances does peptide therapy usually include?

Outside mainstream prescribing, the names that come up most fall into a few families, grouped here by the goal people use them for:

• Recovery and injury: BPC-157 and TB-500, often taken together.
• Growth hormone and body composition: CJC-1295, ipamorelin and tesamorelin, which prompt the pituitary to release more of the body’s own growth hormone.
• Weight and metabolism: the approved GLP-1 medicines, the investigational retatrutide, and MOTS-c, plus 5-Amino-1MQ, which is sold alongside peptides but is a small molecule.
• Focus and mood: Semax and Selank, usually as nasal sprays.
• Immune support: thymosin alpha-1.
• Skin and longevity: GHK-Cu and epitalon.

Each of these links goes to our full overview of that substance, with its own sources.

How much evidence is behind each peptide?

Very different amounts. The table grades the evidence in words, from approved drugs with large randomized trials down to compounds tested only in animals and cells. For substances beyond this table, PeptideAgent’s peptide database gives each of 82 peptides an evidence grade, its current FDA and WADA status, and numbered primary sources.

The pattern is hard to miss. The peptides with the strongest evidence are the ones your doctor already prescribes, and the peptides that dominate wellness marketing sit mostly at the bottom of the table. Dr. Tam’s summary to the AMA was that for these newer injections, there just isn’t enough valuable, statistically significant evidence to recommend them safely.

What is peptide therapy used for?

People use it for five broad goals: weight loss, body composition, injury recovery, focus or mood, and anti-aging. Only the first has approved, well-tested options, the GLP-1 medicines in the table above. For the others, the evidence usually stops at animals or at hormone measurements in small groups of healthy volunteers.

That gap is easy to miss because the marketing borrows the language of the approved drugs. CJC-1295 is a good example: its published trials in healthy adults showed dose-dependent rises in growth hormone and IGF-1 (Teichman et al., 2006), but raising a hormone level is not the same as building muscle or losing fat, and those trials did not measure either outcome. BPC-157 is the clearest case on the recovery side. Dr. Tam told the AMA the most-studied claim for these newer injections is recovery, resting on one human study of about 10 to 12 people with knee pain, which appears to be the same retrospective report of 12 patients that the 2025 review counted as its single clinical study (Vasireddi et al., 2025).

What are the side effects of peptide therapy?

They depend on the peptide, and for most wellness peptides they are simply not well documented. For the approved drugs, side effects are measured in large trials: nausea and diarrhea were the most common with semaglutide in STEP 1, usually mild to moderate and fading with time (Wilding et al., 2021), and gastrointestinal effects were also the most common with tirzepatide, mostly during dose increases (Jastreboff et al., 2022).

For the newer peptides, Dr. Tam told the AMA that injection-site irritation, fatigue, headaches and gut upset have been reported, but that there’s still a lot we don’t know. The 2025 BPC-157 review found no clinical safety data at all, and warned that adverse effects are possible because of unregulated manufacturing, contamination or unknown clinical safety (Vasireddi et al., 2025). Growth-hormone peptides carry their own concerns, which users raise too, some linking the DAC version of CJC-1295 to insulin resistance and joint pain (CJC-1295 community page); the approved one, tesamorelin, has label warnings about blood sugar and raised IGF-1 (Egrifta WR label). Our full breakdown is in what the evidence shows about peptide side effects.

Why is peptide therapy sold as stacks and blends?

Because the community thinks in combinations, and clinics and sellers follow. The logic usually comes from mechanism: CJC-1295 is a long-acting analog of growth hormone-releasing hormone (Teichman et al., 2006) and ipamorelin binds the ghrelin receptor (ipamorelin overview), so users pair them to hit growth-hormone release from two sides. BPC-157 and TB-500 are paired as a recovery duo, and Semax and Selank as a focus-and-calm pair.

The evidence problem gets worse with combinations, not better. Each peptide in a stack has thin human data on its own, and none of the studies cited on this page tested a combination, so the pairs’ combined effects and safety are an open question. A premixed blend adds one more unknown: you cannot judge it against either peptide alone without knowing how much of each it contains. Our overviews of CJC-1295 and BPC-157 walk through the best-known pairings.

How much does peptide therapy cost?

There is no single price, because peptide therapy is not one product. The bill is usually built from a provider or membership fee, lab work, and the medication itself, and each of those varies by provider and by how long a supply you buy. Approved drugs such as Wegovy and Zepbound have manufacturer self-pay programs that publish their prices; unapproved peptides have no list price at all, so the number is whatever a given clinic or seller sets.

Cost is also an ongoing question rather than a one-off: the approved GLP-1 medicines are ongoing treatments that their manufacturers price by the month rather than a single course. Our 2026 peptide and GLP-1 cost index breaks down the fees, labs and supply lengths, with dated figures from manufacturer sources.

Is peptide therapy worth it?

It depends entirely on which peptide, which is why “peptide therapy” is a poor unit for the decision. For approved GLP-1 medicines the trials let you weigh a large, measured benefit against a known cost and known side effects. For most wellness peptides you are paying for an outcome the trials have not established, on top of quality questions that compounded and research-use products carry. Our opinion piece, is peptide therapy worth it?, works through that trade-off in more detail.

What are people saying about peptide therapy?

Online, peptide therapy is discussed less as a treatment than as a hobby: people build stacks, compare tier lists and trade first-hand reports. In the X posts our community tracker collected in July 2026, a few patterns stood out:

• Stacks are the default. In 17 posts on CJC-1295 (July 13 to 19), many users described running it with ipamorelin rather than alone (CJC-1295 community page). In 16 posts on TB-500 (July 14 to 19), users framed it as the recovery half of a pair with BPC-157 (TB-500 community page). Semax and Selank posts described the same habit for focus and calm (Semax community page, Selank community page).
• Users want first-hand accounts, not brochures. Several CJC-1295 posters said most write-ups they find are either dry clinical summaries or vendor pages (CJC-1295 community page).
• Hype fatigue is real. In 19 MOTS-c posts (July 16 to 19), one commenter compared the peptide to earlier fads and mocked people who jump on each new compound, while another said he had been prepared to trash it before reassessing it after a month of use (MOTS-c community page).
• Conflicts of interest come up. In 16 epitalon posts (July 16 to 19), some posters listing long multi-peptide routines noted their own affiliate relationships (epitalon community page).

These are self-reports from one platform over short windows, not evidence that any peptide works or is safe. What they do show is how far the online meaning of “peptide therapy” has drifted from the medical one: from a prescribed drug for a diagnosis to a personal experiment shared in public.

Status: It differs by substance; most of the peptides named on this page are not FDA-approved. Our peptide status explainer gives one dated, plain-English line for each.

Educational information only, not medical advice. Trial results are cited to their primary sources. Updated October 12, 2026.